Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001586785-26-000004

Chief Executive Officer gave up 21,892 shares (to pay taxes)

  • Chief Executive Officer acquired 64,866 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NEIL GARRY ARTHUR Chief Executive Officer 2026-03-28 Option exercise +64,866 112,006 D: show line 1 in the form
NEIL GARRY ARTHUR Chief Executive Officer 2026-03-28 Shares withheld for taxes −21,892 $13.89 $304,080 90,114 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
NEIL GARRY ARTHUR Chief Executive Officer 2026-03-28 Option exercise · Restricted Stock Units −64,866 64,867 D: show line 3 in the form
Loading xslF345X06/form4-03312026_080315.xml…